US EditionFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries
Summary by aboutlawsuits.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries
BioZorb markers failed to properly absorb into the women’s bodies, leading to infections and other serious complications. Hologic, Inc. is facing a multi-plaintiff lawsuit from women who received the company’s BioZorb implant during breast cancer treatment, and later experienced complications that required surgical removal and reignited fears about a possible…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
